Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year


About Japan Tissue Engineering

Japan Tissue Engineering (TYO: 7774) is a provider of medical biotechnology services. The Company develops regenerative medicine using tissue engineering technology. The company also provides research support services. It operates through the Regenerative Medicine and Research and Development (R&D) Support segments. The Regenerative Medicine segment develops, manufactures, and sells tissue-engineered medical products through autologous culturing techniques. The R&D Support segment deals with the research of cultured human tissues. The company was founded on February 1, 1999 and is headquartered in Gamagori, Japan.

Japan Tissue Engineering Headquarter Location


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Japan Tissue Engineering

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Japan Tissue Engineering is included in 1 Expert Collection, including Regenerative Medicine.


Regenerative Medicine

1,708 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.